Zhiheng Wu

Title: Zhiheng Wu: Innovator in Terminal Technologies and Pharmaceuticals

Introduction

Zhiheng Wu is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of terminal technologies and pharmaceuticals. With a total of 2 patents, his work reflects a commitment to enhancing user experience and advancing cancer treatment.

Latest Patents

One of his latest patents is a split-screen display method for terminals. This invention provides a split-screen display method and an apparatus that improves user experience by displaying detailed information about intelligent prompt information on split screens. The method is applicable to terminals with at least one display and involves obtaining intelligent prompt information and displaying it in a designated area of the display.

Another notable patent is related to a macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one. This compound serves as a Wee1 inhibitor and is used in chemotherapy or radiotherapy for cancers. The macrocyclic derivative effectively inhibits Wee1 and related signaling pathways, demonstrating good therapeutic effects on cancer treatment.

Career Highlights

Zhiheng Wu has worked with notable companies such as Huawei Technologies Co., Limited and Shanghai De Novo Pharmatech Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative technologies and pharmaceutical solutions.

Collaborations

Some of his coworkers include Honglei Luo and Wei Zhao. Their collaboration has likely fostered an environment of innovation and creativity in their respective fields.

Conclusion

Zhiheng Wu's contributions to terminal technologies and pharmaceuticals highlight his role as an influential inventor. His patents not only improve user experience but also offer promising solutions for cancer treatment.